Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

688

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Major Depressive DisorderTreatment Resistant Depression
Interventions
DRUG

Quetiapine XR

300 mg once daily (od)

DRUG

Lithium carbonate

900 mg once daily (od)

DRUG

SSRI/Venlafaxine

SSRI - doses within label, Venlafaxine dose up to 225 mg/day

Trial Locations (106)

Unknown

Research Site, Garran

Research Site, Brisbane

Research Site, Everton Park

Research Site, Townsville

Research Site, Gilberton

Research Site, Clayton

Research Site, Frankston

Research Site, Heidelberg

Research Site, Malvern

Research Site, Prahran

Research Site, Richmond

Research Site, Graz

Research Site, Klagenfurt

Research Site, Salzburg

Research Site, Vienna

Research Site, Wels

Research Site, Wiener Neustadt

Research Site, Assebroek

Research Site, Diest

Research Site, Liège

Research Site, Tielt

Research Site, Cerova Koria Village

Research Site, Kardzhali

Research Site, Pazardzhik

Research Site, Pleven

Research Site, Rousse

Research Site, Sofia

Research Site, Varna

Research Site, Esbjerg N

Research Site, Frederiksberg

Research Site, Odense

Research Site, Aachen

Research Site, Achim

Research Site, Augsburg

Research Site, Bad Homburg

Research Site, Bad Honnef

Research Site, Bad Saarow

Research Site, Berlin

Research Site, Bielefeld

Research Site, Bochum

Research Site, Butzbach

Research Site, Chemnitz

Research Site, Dresden

Research Site, Düren

Research Site, Düsseldorf

Research Site, Ellwangen

Research Site, Erbach im Odenwald

Research Site, Gelsenkirchen

Research Site, Gütersloh

Research Site, Halle

Research Site, Hattingen

Research Site, Herborn

Research Site, Kassel

Research Site, Köthen

Research Site, Neu-Isenburg

Research Site, Neubrandenburg

Research Site, Nuremberg

Research Site, Oldenburg

Research Site, Ostfildern

Research Site, Schwerin

Research Site, Stuttgart

Research Site, Westerstede

Research Site, Würzburg

Research Site, Budapest

Research Site, Győr

Research Site, Gyula

Research Site, Nyíregyháza

Research Site, Brixen

Research Site, Bruneck

Research Site, Cagliari

Research Site, Pisa

Research Site, Roma

Research Site, Bolzano

Research Site, Catania

Research Site, Napoli

Research Site, Roma

Research Site, Braga

Research Site, Coimbra

Research Site, Lisbon

Research Site, Santarém

Research Site, Galati

Research Site, Bucharest

Research Site, Craiova

Research Site, Sibiu

Research Site, Bratislava

Research Site, Krupina

Research Site, Levice

Research Site, Liptovský Mikuláš

Research Site, Michalovce Stranany

Research Site, Prešov

Research Site, Rožňava

Research Site, Zilina-bytcica

Research Site, Zlaté Moravce

Research Site, Salamanca

Research Site, Zamora

Research Site, Barcelona

Research Site, Vigo

Research Site, Langreo

Research Site, Addlestone

Research Site, Winnick

Research Site, Horsham

Research Site, Coventry

Research Site, Glasgow

Research Site, Harrow

Research Site, Hull

Research Site, Winsford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY